VERU INC. (VERU): auditor change — Veru restates FY2023 financials for R&D expense overstatement; cash runway extends

VERU INC.

Audit committee concludes FY2023 financials cannot be relied upon due to overestimated R&D expenses.
Overestimation of R&D costs results in cash on hand expected to last longer than previously stated.
Company evaluating impact on FY2022 audited financials and interim quarters of FY2022 and FY2023.
Veru intends to file amended periodic reports; discussed with auditor RSM US LLP.

item 4.02

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

VERU INC. reported that prior financial statements should not be relied upon.

Action: non reliance

Exact text from the filing

On February 15, 2024, the Audit Committee of the Board of Directors of Veru Inc. (the “Company”), based on the recommendation of management, concluded that the Company’s previously issued consolidated financial statements as of and for the year ended September 30, 2023 (the “Prior Financial Statements”) should no longer be relied upon due to errors

View on SEC.gov

8 auditor changes filed in the last 30 days. Browse all auditor changes →

VERU INC. filing history →

Source: SEC EDGAR

accession 0001193125-24-037535

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.